Showing 1 - 6 results of 6 for search 'David Castro-Díaz', query time: 0.03s Refine Results
  1. 1
    Editorial for the Abstracts of the 21st Meeting of the Association of Academic European Urologists [European Urology Open Science 2024;60 (Suppl 1):S1-39]

    Editorial for the Abstracts of the 21st Meeting of the Association of Academic European Urologists [European Urology Open Science 2024;60 (Suppl 1):S1-39] by John Heesakkers, Frans Debruyne, David Castro Diaz

    Published 2024-05-01
    Get full text
    Article
  2. 2
    Long-term Outcomes of Sacral Nerve Stimulation in Pelvic Floor Dysfunctions

    Long-term Outcomes of Sacral Nerve Stimulation in Pelvic Floor Dysfunctions by David Hernández-Hernández, Bárbara Padilla-Fernández, Milagros Castro Romera, Stephany Hess Medler, David Castro-Díaz

    Published 2021-12-01
    Get full text
    Article
  3. 3
    Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study

    Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUAL... by Antonio Alcaraz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez, David Castro-Díaz, Manuel Esteban-Fuertes, José M. Cózar-Olmo, Vincenzo Ficarra, Rafael Medina-López, Jesús M. Fernández-Gómez, Javier C. Angulo, José Medina-Polo, Francisco J. Brenes-Bermúdez, José M. Molero-García, Antonio Fernández-Pro-Ledesma, José Manasanch, on behalf of The QUALIPROST Study Group

    Published 2020-09-01
    Get full text
    Article
  4. 4
    Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients

    Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients by Antonio Alcaraz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez, David Castro-Díaz, José Medina-Polo, Jesús M. Fernández-Gómez, Vincenzo Ficarra, Joan Palou, Javier Ponce de León Roca, Javier C. Angulo, Manuel Esteban-Fuertes, José M. Cózar-Olmo, Noemí Pérez-León, José M. Molero-García, Antonio Fernández-Pro Ledesma, Francisco J. Brenes-Bermúdez, José Manasanch

    Published 2021-09-01
    Get full text
    Article
  5. 5
    Efficacy and Safety of the Hexanic Extract of <em>Serenoa repens</em> vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study

    Efficacy and Safety of the Hexanic Extract of <em>Serenoa repens</em> vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study by Antonio Alcaraz, Mauro Gacci, Vincenzo Ficarra, José Medina-Polo, Andrea Salonia, Jesús M. Fernández-Gómez, Alexandru Ciudin, David Castro-Díaz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez, José M. Cózar-Olmo, Santiago Búcar-Terrades, Noemí Pérez-León, Francisco J. Brenes-Bermúdez, José M. Molero-García, Antonio Fernández-Pro Ledesma, Michael Herdman, José Manasanch, Javier C. Angulo, on behalf of the QUALIPROST Study Group

    Published 2022-02-01
    Get full text
    Article
  6. 6
    Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of <i>Serenoa repens</i> versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study

    Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of <i>Serenoa repens</i> versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to... by Antonio Alcaraz, David Castro-Díaz, Mauro Gacci, Andrea Salonia, Vincenzo Ficarra, Joaquín Carballido-Rodríguez, Alfredo Rodríguez-Antolín, José Medina-Polo, Jesús M. Fernández-Gómez, José M. Cózar-Olmo, Santiago Búcar-Terrades, Noemí Pérez-León, Francisco J. Brenes-Bermúdez, José M. Molero-García, Antonio Fernández-Pro-Ledesma, Michael Herdman, Javier C. Angulo, José Manasanch, on behalf of the QUALIPROST Study Group

    Published 2022-06-01
    Get full text
    Article

Search Tools: